Pro-GeneX, Robert Rupard and Brett Grauss Our approach to the testing business is that we re not a pharmacogenomics company, we re a risk management company that uses a variety of tools to solve problems. During the past decade, the field of pharmacogenomics/pharmacogenetics (PGx) has grown exponentially due to advances in science and clinical experience. This growth [...]